Slovakian experience with continuous infusion of factor VIII for surgery in hemophilia A and von Willebrand disease

被引：0
作者：
Batorova, A
Filova, A
Pappova, K
Martinowitz, U
机构：
[1] UNIV HOSP, NATL HEMOPHILIA CTR, INST HEMATOL, BRATISLAVA, SLOVAKIA
[2] CHAIM SHEBA MED CTR, NATL HEMOPHILIA CTR, IL-52621 TEL HASHOMER, ISRAEL
来源：
THROMBOSIS AND HAEMOSTASIS | 1997年
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：PS227 / PS227
页数：1
相关论文
共 50 条
[41]   Efficacy and safety of factor VIII/von Willebrand factor concentrate Haemate P in von Willebrand patients undergoing surgery [J].
Zotz, R. ;
Mandaliev, A. ;
Moeller, N. ;
Scharf, R. .
HAEMOPHILIA, 2008, 14 :118-118
[42]   Continuous infusion of factor VIII for surgery and major bleeding [J].
Hay, CRM ;
Doughty, HI ;
Savidge, GF .
BLOOD COAGULATION & FIBRINOLYSIS, 1996, 7 :S15-S19
[43]   Undetected factor VIII level in a type III von Willebrand disease (vWD) patient masquerading as severe hemophilia [J].
Mullah-Ali, AM ;
Chan, A ;
Pai, MK ;
Decker, K ;
Moffat, KA ;
Walker, I .
BLOOD, 2005, 106 (11) :104B-104B
[44]   Pharmacokinetic evaluation of Von Willebrand factor/factor VIII concentrate (Humate-P@) prior to elective surgery in patients with Von Willebrand disease. [J].
Di Paola, Jorge ;
Gill, Joan ;
Bemstein, Jonathan ;
Leissinger, Cindy ;
Ragni, Margaret ;
Shopnik, Rinah ;
Valentino, Leonard ;
Friedman, Carl ;
Knaub, Sigurd .
BLOOD, 2006, 108 (11) :98B-99B
[45]   Pharmacokinetics and dose linearity of von Willebrand factor factor VIII concentrate (Humate-P®) in elective surgery in von Willebrand disease patients. [J].
DiPaola, J ;
Gill, J ;
Bernstein, J ;
Leissinger, C ;
Valentino, L ;
Friedman, C ;
Knaub, S .
BLOOD, 2005, 106 (11) :509A-510A
[46]   Impact of obesity on factor VIII and von Willebrand factor levels in patients with Type 1 von Willebrand disease and low von Willebrand factor: An analysis of the ATHNdataset [J].
Schaefer, Beverly A. ;
Cheng, Dunlei ;
Kouides, Peter .
HAEMOPHILIA, 2022, 28 (01) :109-116
[47]   Continuous infusion of human plasma-derived von Willebrand factor concentrate as an effective therapy in a patient with acquired von Willebrand disease [J].
Patel, S. B. ;
Rodgers, G. M. .
HAEMOPHILIA, 2014, 20 (06) :E411-E414
[48]   Continuous infusion of recombinant factor VIIa (NovoSeven®) in the treatment of a patient with type III von Willebrand's disease and alloantibodies against von Willebrand factor [J].
Grossmann, RE ;
Geisen, U ;
Schwender, S ;
Keller, F .
THROMBOSIS AND HAEMOSTASIS, 2000, 83 (04) :633-634
[49]   Continuous infusion of a FVIII/VWF concentrate for major surgery in 3 patients with von Willebrand disease [J].
Grimley, Charlotte ;
Dolan, Gerard .
HAEMOPHILIA, 2014, 20 :114-114
[50]   Factor VIII and von Willebrand activity are strongly related to the desmopressin biological response in von willebrand disease [J].
Sanchez-Luceros, A. ;
Woods, A., I ;
Meschengieser, S. S. ;
Grosso, S. ;
Lazzari, M. A. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 :528-528
12345